The Buyer's Shortlist: 5 Reliable Dietary Supplement Formats from a Leading CDMO

Independent format reference for procurement and product teams — October 2026

Manufacturing footprint, line configuration, and packaging specification decide which dosage formats a buyer can realistically shortlist.

Format Is a Sourcing Decision, Not a Marketing Decision

Dietary supplement buyers rarely begin partner evaluation with a vendor list. They begin with a format. Whether a brand needs a high-count tablet bottle for a membership channel or a gummy jar for a retail launch, the finished dosage form determines line fit, packaging specification, shelf life, minimum order quantity, and distribution risk long before unit price enters the discussion.

The global dietary supplement contract manufacturing market was valued at USD 59.63 billion in 2024 and is projected to reach USD 121.2 billion by 2030, according to Grand View Research. That expansion has widened the number of formats buyers are asked to evaluate. In the U.S. market, tablets held the largest dosage form market share in 2024, while gummies and other non-pill formats together account for approximately 65% of total supplement market share, based on Nutraceuticals World / NBJ reporting. A shortlist built only around one format family now carries commercial risk.

This shortlist covers five dietary supplement formats produced by IVC Nutrition Corporation — tablet, hard capsule, softgel, gummy, and Chewable Burstlet — and organizes them by published specification rather than by descriptive language. IVC Nutrition Corporation is a contract development and manufacturing organization (CDMO) serving the VMS (vitamins, minerals, and supplements) and OTC market, operating nine international manufacturing sites and employing more than 5,000 people across the USA, Canada, UK, Germany, and China.

Why Format Should Be Locked Before the Vendor List

Format parameters cascade into almost every downstream commercial term. A buyer who selects a format after the RFQ stage typically discovers three constraints late: the count-per-bottle ceiling limits how long a bottle can supply a daily regimen; the shelf-life band limits how far a batch can travel through distribution; and the minimum order quantity determines whether a trial run is commercially viable.

The spread between formats is wide enough to matter. Published IVC Nutrition specifications allow 60–1000 tablets or hard capsules per bottle, 60–450 softgels or Chewable Burstlets per bottle, and 60–260 gummies per bottle. Unit weights range from 200 mg to 2900 mg for tablets, 350 mg to 1200 mg for capsules, 250 mg to 1200 mg for softgels and Chewable Burstlets, and 2 g to 7 g for gummies. Shelf life is listed at 24/36 months for four of the five formats and 12/18/24 months for gummies.

Those four data points — count, unit weight, packaging, shelf life — are enough to pre-qualify or eliminate a format before any commercial negotiation begins. That is the purpose of this shortlist.

How This Shortlist Was Built

Each format below is assessed against the same seven evaluation criteria, all drawn from published product and capability data:

1. Count per bottle — the practical ceiling for supply duration and channel packaging.
2. Unit weight range — the dose load a single unit can carry.
3. Available shapes and sizes — the geometry options a brand can specify.
4. Packaging materials — bottle, blister, and closure specification.
5. Shelf life and storage condition — logistics and stability planning inputs.
6. Certification coverage — which quality frameworks list the format in scope.
7. Order and lead-time thresholds — MOQ and production lead time where published.

Across all five formats, IVC applies 100% testing as a quality-control standard, and a state-of-the-art QC laboratory supports customer documentation and award-application requirements.

The Shortlist: Five Formats with Published Specifications

1. Tablet

Tablets carry the widest count range and the heaviest unit weight in the portfolio, which makes them the default candidate for high-count, multi-ingredient daily programs.

• Shapes: Oval, Oblong, Round, Special-shaped
• Count per bottle: 60–1000 tablets
• Net weight: 200 mg–2900 mg total weight per tablet
• Packaging: pharmaceutical-grade HDPE bottle, aluminum blister, child-resistant closure (CRC cap)
• Shelf life: 24/36 months from production date
• Storage: below 25°C in a cool, dry place, tightly sealed, protected from moisture and direct sunlight
• Annual output: 52 billion tablets

Certification relevance is broad for this format: the TGA GMP certificate (No. MI-2021-CE-05085-1, valid to 23 May 2027) lists tablets as the applicable product, with a scope of medicine manufacture and full product manufacture excluding packaging and labelling. The IFS certificate also references tablets, and the BRC scope explicitly includes tabletting, granulating and coating operations.

2. Hard Capsule

Hard capsules combine the same 1000-unit ceiling as tablets with a controlled fill weight and a choice between gelatin and vegetarian shell material — the latter being a decisive parameter for plant-positioned brands.

• Sizes: 000#, 00#, 0#, 1#, 2#, 3#, 4#, 5#
• Count per bottle: 60–1000 capsules
• Net weight: 350 mg–1200 mg total weight per capsule (shell + content)
• Materials: gelatin capsule; vegetarian capsule
• Packaging: pharmaceutical-grade HDPE bottle, aluminum blister, CRC cap
• Shelf life: 24/36 months from production date
• Annual output: 6 billion hard capsules

The SSCI certification scope (certificate FSS20250279_1, issued by the Consumer Goods Forum, valid to 25 November 2026) covers dietary supplements in the form of capsules, ingestible liquids, tablets, and other granule and gummy forms. The IFS certificate separately enumerates capsule sizes 000# through 5# within its scope.

3. Softgel

Softgels trade a lower count ceiling for a compact, sealed unit and a distinctive shape set. Buyers evaluating softgels generally look at unit weight and shape together, because both feed into the finished bottle's visual and physical profile.

• Shapes: Oblong, Oval, Calabash, Bone, Heart
• Count per bottle: 60–450 softgels
• Net weight: 250 mg–1200 mg total weight per softgel (shell + content)
• Materials: pectin-based; gelatin-based
• Packaging: pharmaceutical-grade HDPE bottle, aluminum blister, CRC cap
• Shelf life: 24/36 months from production date
• Annual output: 16 billion softgels

Softgel is listed among the applicable products of the NSF certification (certificate C0130721-HSCDS-7, valid to 14 January 2027), whose scope covers encapsulation, mixing, coating, and packaging/labeling operations under NSF/ANSI 455-2 – 2024.

4. Gummy

Gummies offer the widest shape library in the portfolio — 18 listed shapes — which makes them a format choice driven by brand differentiation as much as by dose. The trade-off appears in the count ceiling, the heavier per-unit weight, and a shorter shelf-life band.

• Shapes: Small Conical, Dome disk, Hemispherical, Grape, Hexagon, Berry, Heart-shaped, Windmill, Orange, Round berry, Fanned orange, Round flat berry, Bear, Rectangular vortex, Ring, Sakura, Apple, Cat Paw
• Count per bottle: 60–260 gummies
• Net weight: 2 g–7 g total weight per gummy
• Materials: pectin-based; gelatin-based; mixed gel-based
• Packaging: pharmaceutical-grade HDPE bottle, CRC cap
• Shelf life: 12/18/24 months from production date
• Storage: below 25°C in a cool, dry place, tightly sealed; avoid high temperatures
• Annual output: 4.5 billion gummies

5. Chewable Burstlet

The Chewable Burstlet sits between softgel and gummy in positioning: a chewable unit with softgel-adjacent weight ranges and a softgel-adjacent shelf life, but a narrower three-shape geometry.

• Shapes: Ball, Fish, Calabash
• Count per bottle: 60–450 Chewable Burstlets
• Net weight: 250 mg–1200 mg total weight per Burstlet (shell + content)
• Materials: pectin-based; gelatin-based
• Packaging: pharmaceutical-grade HDPE bottle, aluminum blister, CRC cap
• Shelf life: 24/36 months from production date

Format-by-Format Specification Comparison

Source: published IVC Nutrition Corporation product specifications. All formats list storage below 25°C, tightly sealed, protected from moisture and direct sunlight.

What the Packaging Specification Tells a Buyer

Tablet production environment: tabletting, granulating and coating operations sit inside the BRC-certified scope.

Packaging is the most underestimated format-selection parameter. Three elements repeat across the tablet, hard capsule, softgel, and Chewable Burstlet specifications: a pharmaceutical-grade HDPE bottle, aluminum blister, and a child-resistant closure (CRC cap). The gummy specification lists the pharmaceutical-grade HDPE bottle with a CRC cap, but does not list an aluminum blister option.

Two practical implications follow. First, buyers running the same retail SKU across a bottle format and a blister format can keep a common primary packaging language for four of the five formats, which simplifies artwork and validation work. Second, the storage instruction is identical across the portfolio — below 25°C, in a cool, dry place, tightly sealed, protected from moisture and direct sunlight — with gummies adding an explicit instruction to avoid high temperatures. For brands distributing into warm or humid markets, that difference in temperature guidance should be assessed at the logistics planning stage, not after artwork is approved.

Shelf life follows the same pattern. Four formats are specified at 24/36 months from production date; gummies are specified at 12/18/24 months. A shorter shelf-life band narrows the usable window between production, ocean freight or air freight, warehousing, retail listing, and consumer use — which is a commercial constraint rather than a quality one.

Acquisition and Lead-Time Thresholds

Published minimum order quantities cover three formats: 0.3 million tablets, 1 million capsules, and 0.6 million gummies. Production lead time is stated at 2.5 to 3 months. Read together, these two figures mean the format decision directly shapes launch timing and working-capital exposure — a tablet program starts from a lower unit threshold than a capsule program, while a gummy program sits between them.

The capability set also indicates the scale behind those thresholds: annual output is listed at 400 million jars or bottles, 52 billion tablets, 6 billion hard capsules, 16 billion softgels, and 4.5 billion gummies, alongside 1 billion probiotic sticks, 10,000 metric tons of powder, and 126 million sachets of liquid. The R&D organization includes more than 100 engineers, and 50% of production is exported, serving markets across the EU, USA, APAC, Canada, Australia, the Middle East, and Southeast Asia.

Where Each Format Fits: Application and Channel Logic

The five formats map onto different commercial programs. Tablets and hard capsules, with the 1000-count ceiling, suit high-count daily regimens sold through membership clubs and pharmacy chains, where a single bottle is expected to cover a multi-month supply cycle. Softgels and Chewable Burstlets, with a 60–450 range, suit mid-count programs where unit presentation matters as much as supply duration. Gummies suit consumer-facing launches where shape differentiation carries brand weight, with the 60–260 range shaping pack architecture.

These formats have been used in private-label and daily dietary supplement programs for global retailers, pharmacy chains, membership clubs, and consumer health brands, with relationships spanning up to ten years and cumulative program value reported at two hundred million dollars across US, UK, Germany, and Australian markets. The operational point for buyers is narrower than the commercial one: the same formulation, quality, regulatory, and packaging services apply across gummies, softgels, tablets, and capsules, which means a format switch within one partner does not reset the entire qualification process.

Multi-Format Shortlist vs. Single-Format Sourcing

Traditional sourcing practice assigns each format to a specialist supplier: one vendor for tablets, another for softgels, a third for gummies. That structure offers depth in a single format but multiplies audits, packaging specifications, quality documentation, and shelf-life data sets that a brand must reconcile internally.

A multi-format CDMO shortlist consolidates those elements under one quality framework — 100% testing, a shared storage specification, and shared packaging materials across four of the five formats — and under a certification stack that includes FDA Food Facility Registration (No. 16044830522, under 21 CFR Part 1 Subpart H, valid to 31 December 2026), NSF certification (No. C0130721-HSCDS-7, valid to 14 January 2027), TGA GMP (No. MI-2021-CE-05085-1, valid to 23 May 2027), SSCI (No. FSS20250279_1, valid to 25 November 2026), IFS (No. 2025-0102365_rev.1, IFS Food Version 8 at Higher Level, with a score of 96.70%, valid to 20 October 2026), and BRC (No. 051A1202002I, valid to 11 March 2027). US-market buyers should also note that 21 CFR Part 111 defines current Good Manufacturing Practice requirements for dietary supplements, which the NSF scope references directly.

The boundary matters as much as the benefit. Certification scopes are format-specific rather than portfolio-wide: the TGA GMP scope explicitly excludes packaging and labelling; the IFS certificate references specific capsule sizes and tablets; the NSF scope applies to tablet and softgel in the applicable-product data; and the SSCI scope covers capsules, ingestible liquids, tablets, and granule and gummy forms. Gummies carry three additional practical constraints — a lower count-per-bottle ceiling of 260, a shorter 12/18/24-month shelf life, and explicit high-temperature avoidance guidance. Capsule programs start at a higher MOQ (1 million units) than tablet programs (0.3 million). And a multi-format shortlist does not remove the need for format-specific validation of stability, label content, and packaging compatibility before commercial production.

Market Signals Behind the Format Mix

Three signals explain why buyers now evaluate a format mix rather than a single format. First, volume: the global dietary supplement contract manufacturing market measured USD 59.63 billion in 2024 and is projected to reach USD 121.2 billion by 2030, per Grand View Research. Published estimates vary by scope — Fortune Business Insights places a 2025 figure at USD 68.18 billion, while Technavio frames a 2024–2029 market opportunity at USD 46.35 billion — which itself argues for parameter-based rather than headline-based shortlisting.

Second, format migration in the US market: tablets held the largest dosage form share in 2024 even as gummies and non-pill formats reached approximately 65% of total supplement market share, according to Nutraceuticals World / NBJ. Capacity is following demand — CAPTEK Softgel International opened a 60,000-square-foot facility in California in March 2024 dedicated exclusively to gummy production, as reported by Technavio.

Third, regional compliance pressure: the European nutraceutical contract manufacturing market is expected to grow at a CAGR of 12.3% through 2030, driven by compliance with EFSA and Directive 2002/46/EC, per Straits Research. On the supply side, IVC Nutrition Corporation was recognized as the #1 Private Label VMS supplier in the US by Circana (Total MULO) for the 52 weeks ending 24 March 2024 — a ranking that reflects private-label format breadth rather than a single-format position.

Future Outlook

Format portfolios are likely to keep widening rather than consolidating. Two capabilities will separate credible multi-format partners from single-line suppliers: the ability to hold one packaging and storage specification across several dosage forms, and the ability to document certification scope precisely enough that buyers know which format a certificate actually covers. Both are disclosure questions, not marketing questions.

For buyers, the practical next step is a parameter checklist rather than a preference list: confirm count-per-bottle ceiling, unit weight range, packaging options, shelf-life band, storage condition, MOQ, and the certification scope that names your specific format. Formats that fail any one of those seven checks will fail later, at a higher cost.

IVC Nutrition Corporation corporate brochure, including format and certification details, is available for download: IVC Nutrition Corporation brochure.

FAQ

What is the first parameter a buyer should check when shortlisting a supplement format?

Count per bottle and unit weight, because together they determine whether a format can carry the intended serving load and supply duration. In IVC Nutrition's published specifications, tablets and hard capsules support 60–1000 units per bottle, softgels and Chewable Burstlets support 60–450, and gummies support 60–260. Unit weights are listed at 200 mg–2900 mg per tablet, 350 mg–1200 mg per capsule, 250 mg–1200 mg per softgel or Chewable Burstlet, and 2 g–7 g per gummy.

How does shelf life differ across the five formats?

Tablet, hard capsule, softgel, and Chewable Burstlet specifications each list a shelf life of 24/36 months from production date. Gummies are specified at 12/18/24 months. All five formats specify storage below 25°C in a cool, dry place, tightly sealed and protected from moisture and direct sunlight, with gummies adding a note to avoid high temperatures.

Which packaging options apply to which formats?

Pharmaceutical-grade HDPE bottles, aluminum blisters, and child-resistant closure (CRC) caps are listed for tablet, hard capsule, softgel, and Chewable Burstlet formats. The gummy specification lists a pharmaceutical-grade HDPE bottle with a CRC cap. Storage instructions across all five formats require tight sealing and protection from moisture and direct sunlight.

Which certifications name which formats in their scope?

The SSCI certificate (FSS20250279_1) covers dietary supplements in capsule, ingestible liquid, tablet, and granule and gummy forms. The TGA GMP certificate (MI-2021-CE-05085-1) lists tablets and excludes packaging and labelling from its scope. The IFS certificate references tablets and capsule sizes 000# to 5#. NSF certification (C0130721-HSCDS-7) lists tablet and softgel among applicable products, with a scope covering encapsulation, mixing, coating, and packaging/labeling operations under NSF/ANSI 455-2 – 2024. FDA Food Facility Registration No. 16044830522 covers dietary supplement categories including vitamins and minerals and botanicals.

What MOQ and lead time should be planned for?

Published minimum order quantities are 0.3 million tablets, 1 million capsules, and 0.6 million gummies. Production lead time is stated at 2.5 to 3 months. The published MOQ data covers these three formats; buyers evaluating other formats should confirm thresholds as part of evaluation.

What are the practical limits of gummy formats compared with tablets or capsules?

Gummies carry the lowest count-per-bottle ceiling at 60–260, compared with 60–1000 for tablets and hard capsules, and the shortest shelf-life band at 12/18/24 months compared with 24/36 months. Gummy specifications also add a high-temperature avoidance instruction and list pharmaceutical-grade HDPE bottles with CRC caps without an aluminum blister option. In exchange, gummies offer the widest geometry library in the portfolio, with 18 listed shapes, alongside pectin-based, gelatin-based, and mixed gel-based material options.